Apple joins other tech companies that have pledged to increase manufacturing in the U.S. because of President Donald Trump's tariffs.

The UK’s National Institute for Health and Care Excellence (NICE) on August 6 recommended the use of US pharma giant Merck & ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of ...

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer ...

NORTHAMPTON, MA / ACCESS Newswire / August 7, 2025 / MilliporeSigmaPaulo Freire, Brazilian educator and philosopher, once said, "Education does not change the world. Education changes people, and peop ...

The demand for treatments targeting myeloproliferative disorders is rising sharply, propelled by several key factors that underscore the market’s robust growth potential. Chief among these is the ...

Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...

Trump has claimed that the TSMC is planning to spend $300 billion to build the world’s largest chip-making facility in ...

Just 15% of women live for five years if they have been diagnosed with advanced (stage four) endometrial cancer – a cancer which usually starts in the lining of the womb. The treatment, pembrolizumab, ...

In June 2025, Iovance Biotherapeutics announced that the Journal of Clinical Oncology has published the final analysis from ...

Microbiotica Announces Completion of Recruitment in its Phase 1b Trial (COMPOSER-1) of MB310, a Precision Microbiome Medicine, in Ulcerative Colitis Patients4 August 2025Cambridge, UK – 4 August 2025: ...